We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-11.14%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$309M
AUM Growth
-$35.7M
Cap. Flow
+$5.78M
Cap. Flow %
1.87%
Top 10 Hldgs %
27.1%
Holding
113
New
2
Increased
38
Reduced
26
Closed
7

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$261K
2
BA icon
Boeing
BA
+$248K
3
TROW icon
T. Rowe Price
TROW
+$214K
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$210K
5
GE icon
GE Aerospace
GE
+$209K

Sector Composition

Rank Sector Weight
1 Healthcare 15.27%
2 Technology 13.05%
3 Industrials 11.58%
4 Consumer Staples 11.18%
5 Consumer Discretionary 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
51
Home Depot
HD
$331B
$2.6M 0.84%
9,500
-50
-0.5% -$14.8K
VTI icon
52
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$2.34M 0.76%
12,402
+22
+0.2% +$4.52K
IJH icon
53
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.22M 0.72%
49,095
+1,120
+2% +$55.3K
HYD icon
54
VanEck High Yield Muni ETF
HYD
$4.43B
$2.1M 0.68%
39,038
+1,242
+3% +$67.8K
CTAS icon
55
Cintas
CTAS
$81.9B
$2.06M 0.67%
22,120
USB icon
56
US Bancorp
USB
$98.2B
$2.04M 0.66%
44,291
WU icon
57
Western Union
WU
$1.98B
$1.97M 0.64%
119,822
-5,992
-5% -$106K
VB icon
58
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$1.97M 0.64%
11,192
IBB icon
59
iShares Biotechnology ETF
IBB
$9.34B
$1.9M 0.61%
16,116
+1,500
+10% +$178K
MGA icon
60
Magna International
MGA
$18.7B
$1.9M 0.61%
34,525
+5,875
+21% +$358K
IAU icon
61
iShares Gold Trust
IAU
$62.9B
$1.85M 0.6%
53,838
BBH icon
62
VanEck Biotech ETF
BBH
$400M
$1.82M 0.59%
12,481
HYG icon
63
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$1.81M 0.59%
24,542
-678
-3% -$52.7K
JNJ icon
64
Johnson & Johnson
JNJ
$618B
$1.73M 0.56%
9,773
LLY icon
65
Eli Lilly
LLY
$1.02T
$1.45M 0.47%
4,473
CVX icon
66
Chevron
CVX
$392B
$1.31M 0.43%
9,063
GOOG icon
67
Alphabet (Google) Class C
GOOG
$4.36T
$1.29M 0.42%
11,780
PFE icon
68
Pfizer
PFE
$143B
$1.25M 0.4%
23,832
VEU icon
69
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.03M 0.33%
20,669
+90
+0.4% +$4.82K
PAYX icon
70
Paychex
PAYX
$41.6B
$873K 0.28%
7,675
SYK icon
71
Stryker
SYK
$125B
$866K 0.28%
4,354
ORCL icon
72
Oracle
ORCL
$374B
$713K 0.23%
10,211
SYY icon
73
Sysco
SYY
$40.8B
$693K 0.22%
8,190
MMM icon
74
3M
MMM
$90.9B
$648K 0.21%
5,992
-48
-0.8% -$5.8K
IBM icon
75
IBM
IBM
$211B
$634K 0.21%
4,496

Similar funds

Boston Research & Management's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Research & Management held 113 positions worth $309M, down 10% from $344M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Research & Management's Q2 2022 filing shows 2 new, 38 increased, 26 reduced and 7 closed positions. Its largest new stake was Qorvo: 29,510 shares worth $2.78M. The largest sale was Tesla, an estimated $261K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Boston Research & Management's largest Q2 2022 buy was Qorvo: 29,510 shares worth $2.78M.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $528K increase.
  • Boston Research & Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $191K.
  • Boston Research & Management fully exited Tesla in Q2 2022, selling an estimated $261K.
  • Boston Research & Management's ten largest holdings make up 27% of its $309M portfolio in Q2 2022.
  • Boston Research & Management opened 2 new positions and closed 7 in Q2 2022.
  • Boston Research & Management's portfolio value fell 10% quarter-over-quarter to $309M.

Based on Boston Research & Management's 13F filing for Q2 2022, filed 11 Aug 2022.